
Sign up to save your podcasts
Or


Shienna Braga, PharmD examines the literature pertaining to dual pathway inhibition for lower extremity arterial disease.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.6
4545 ratings
Shienna Braga, PharmD examines the literature pertaining to dual pathway inhibition for lower extremity arterial disease.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

78,294 Listeners

262 Listeners

290 Listeners

3,338 Listeners

56,404 Listeners

43 Listeners

401 Listeners

12 Listeners

18 Listeners

15 Listeners

9 Listeners

13,941 Listeners

14 Listeners

5 Listeners